Upcoming HERA call under EU4Health – Next-Generation Influenza Vaccines

The European Health Emergency Preparedness and Response Authority (HERA) has announced a new call for proposals under the EU4Health program, aimed at enhancing Europe’s preparedness against health threats. This funding opportunity focuses on accelerating the development of next-generation influenza vaccines. With a significant budget allocation, this initiative seeks to foster innovation in medical countermeasures, strengthen public health strategies, and ensure faster responses to emerging health crises.
Researchers, biotech firms, and healthcare stakeholders are encouraged to submit their proposals before the deadline.
Multiple Sourcing Framework Contracts to Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines
Scope: This call for tenders seeks to accelerate the development of next-generation, rapidly scalable influenza vaccines with innovative production platforms, novel administration routes, broad protection against pandemic influenza A viruses, and intrinsic immunogenicity, through a phased Pre-Commercial Procurement process. This is a competitive procedure with negotiation with a maximum contract duration of 98 months.
Deadline for receipt of requests to participate: 19.5.2025 15:00 Europe/Brussels
Estimated total value: EUR 225Mio (per service contract established = phase 1 – EUR 12.95Mio, Phase II – EUR 35Mio (estimate), and Phase III – EUR 100Mio (estimate) – see ‘tender specifications’ document)
Read more: Next-generation Influenza Vaccine F&Ts Application Webpage
Source: Business Finland
Image: Chokniti Khongchum